Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah-Maria Fendt

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Cancer Research|July 29, 2020
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid AnabolismRosanna Dattilo, Carla Mottini, Emanuela Camera, et al.
Nature|August 21, 2020
Age-induced accumulation of methylmalonic acid promotes tumour progressionAna P Gomes, Didem Ilter, Vivien Low, et al.
Nature Immunology|February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumorsHaiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Leukemia|March 10, 2019
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.
Molecular Cancer Therapeutics|November 18, 2020
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor GrowthShauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi, et al.
Cancer Research|May 21, 2013
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolismSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2016
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancersEdouard Mullarky, Natasha C Lucki, Reza Beheshti Zavareh, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2023
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapyAli Talebi, Vincent de Laat, Xander Spotbeen, et al.
Gut|December 24, 2018
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacityHannelie Korf, Johannie du Plessis, Jos van Pelt, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Cancer Research|July 29, 2020
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid AnabolismRosanna Dattilo, Carla Mottini, Emanuela Camera, et al.
Nature|August 21, 2020
Age-induced accumulation of methylmalonic acid promotes tumour progressionAna P Gomes, Didem Ilter, Vivien Low, et al.
Nature Immunology|February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumorsHaiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Leukemia|March 10, 2019
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.
Molecular Cancer Therapeutics|November 18, 2020
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor GrowthShauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi, et al.
Cancer Research|May 21, 2013
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolismSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2016
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancersEdouard Mullarky, Natasha C Lucki, Reza Beheshti Zavareh, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2023
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapyAli Talebi, Vincent de Laat, Xander Spotbeen, et al.
Gut|December 24, 2018
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacityHannelie Korf, Johannie du Plessis, Jos van Pelt, et al.
Pageof 15